A Study of Vemurafenib in Participants With Metastatic Melanoma

Clinical trial NCT01307397 · COMPLETED

Trial details

NCT number: NCT01307397
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2011-03-01
Primary completion: 2016-02-24
Enrollment: 3219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.